Quest Diagnostics Incorporated
DGX
$168.48
$0.62630.37%
NYSE
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 15.19% | 12.09% | 14.55% | 8.41% | 2.52% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 15.19% | 12.09% | 14.55% | 8.41% | 2.52% |
| Cost of Revenue | 14.41% | 12.71% | 13.37% | 8.64% | 2.78% |
| Gross Profit | 16.71% | 10.84% | 17.03% | 7.94% | 2.02% |
| SG&A Expenses | 17.72% | 6.19% | 12.78% | 15.20% | 2.23% |
| Depreciation & Amortization | 34.48% | 34.48% | 37.04% | 18.52% | 3.57% |
| Other Operating Expenses | 100.00% | 0.00% | 300.00% | -200.00% | -- |
| Total Operating Expenses | 15.41% | 11.63% | 13.73% | 9.94% | 2.73% |
| Operating Income | 13.93% | 15.00% | 19.87% | 0.00% | 1.39% |
| Income Before Tax | 25.16% | 7.30% | 24.08% | -0.98% | -3.09% |
| Income Tax Expenses | 31.08% | -10.61% | 70.00% | -4.41% | -1.33% |
| Earnings from Continuing Operations | 23.33% | 12.98% | 15.12% | 0.00% | -3.61% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -27.27% | -7.14% | -7.69% | 8.33% | 21.43% |
| Net Income | 23.14% | 13.40% | 15.63% | 0.44% | -2.55% |
| EBIT | 13.93% | 15.00% | 19.87% | 0.00% | 1.39% |
| EBITDA | 15.94% | 16.51% | 20.91% | 3.02% | 2.11% |
| EPS Basic | 22.14% | 13.48% | 15.62% | 0.89% | -1.68% |
| Normalized Basic EPS | 12.71% | 7.51% | 13.24% | -2.13% | -1.41% |
| EPS Diluted | 21.67% | 12.79% | 20.21% | 1.53% | -0.98% |
| Normalized Diluted EPS | 12.72% | 6.56% | 12.22% | -1.27% | -0.54% |
| Average Basic Shares Outstanding | 0.90% | 0.00% | -0.89% | 0.00% | -0.89% |
| Average Diluted Shares Outstanding | 0.89% | 0.89% | 0.00% | -0.88% | -1.75% |
| Dividend Per Share | 6.67% | 6.67% | 5.63% | 5.63% | 5.63% |
| Payout Ratio | -0.13% | -0.06% | -0.09% | 0.05% | 0.08% |